Optical coherence tomography (OCT) measurements and cognitive performance in multiple sclerosis: a systematic review and meta-analysis
暂无分享,去创建一个
[1] J. Komendziński,et al. Retinal nerve fiber and ganglion cell complex layer thicknesses mirror brain atrophy in patients with relapsing-remitting multiple sclerosis. , 2022, Restorative neurology and neuroscience.
[2] Cláudia Sousa,et al. Cognitive impairment and markers of optical neurodegeneration in early multiple sclerosis , 2022, Neurological Sciences.
[3] O. Ciccarelli,et al. Visual Function and Brief Cognitive Assessment for Multiple Sclerosis in Optic Neuritis Clinically Isolated Syndrome Patients , 2021, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[4] D. Parums. Editorial: Review Articles, Systematic Reviews, Meta-Analysis, and the Updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 Guidelines , 2021, Medical science monitor : international medical journal of experimental and clinical research.
[5] A. Achiron,et al. Optical Coherence Tomography Is Associated With Cognitive Impairment in Multiple Sclerosis , 2021, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.
[6] G. Kaubrys,et al. Cognitive Decline in Multiple Sclerosis Is Related to the Progression of Retinal Atrophy and Presence of Oligoclonal Bands: A 5-Year Follow-Up Study , 2021, Frontiers in Neurology.
[7] R. Zivadinov,et al. Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis , 2021, Journal of the Neurological Sciences.
[8] H. Hartung,et al. Association of Retinal Layer Thickness With Cognition in Patients With Multiple Sclerosis , 2021, Neurology: Neuroimmunology & Neuroinflammation.
[9] S. Khoury,et al. Effect of fingolimod vs interferon treatment on OCT measurements and cognitive function in RRMS. , 2021, Multiple sclerosis and related disorders.
[10] J. Schuman,et al. APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies , 2021, Neurology.
[11] F. Leutmezer,et al. Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis , 2021, European journal of neurology.
[12] S. G. Yılmaz,et al. Retinal Nerve Fiber Layer Thickness Correlates with Serum and Cerebrospinal Fluid Neurofilament Levels and is Associated with Current Disability in Multiple Sclerosis. , 2021, Noro psikiyatri arsivi.
[13] R. Benedict,et al. Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both? , 2021, Journal of Neurology.
[14] R. Benedict,et al. Thalamic Nuclei Volumes and Their Relationships to Neuroperformance in Multiple Sclerosis: A Cross‐Sectional Structural MRI Study , 2020, Journal of magnetic resonance imaging : JMRI.
[15] F. Leutmezer,et al. Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis , 2020, Multiple sclerosis journal - experimental, translational and clinical.
[16] F. Leutmezer,et al. Macular ganglion cell–inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis , 2020, Multiple sclerosis.
[17] Ahmed Esmael,et al. Retinal thickness as a potential biomarker of neurodegeneration and a predictor of early cognitive impairment in patients with multiple sclerosis , 2020, Neurological research.
[18] D. Galimberti,et al. Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study , 2020, Neurological Sciences.
[19] M. Hoffmann,et al. MS optic neuritis-induced long-term structural changes within the visual pathway , 2020, Neurology: Neuroimmunology & Neuroinflammation.
[20] F. Foley,et al. Can semantic fluency be used as an alternative or additional measure in the abbreviated Minimal Assessment of Cognitive Function in Multiple Sclerosis (aMACFIMS)? , 2019, Journal of the Neurological Sciences.
[21] T. Olsson,et al. Retinal nerve fiber layer thickness associates with cognitive impairment and physical disability in multiple sclerosis. , 2019, Multiple sclerosis and related disorders.
[22] Rehab Magdy,et al. Early detection of cognitive dysfunction in patients with multiple sclerosis: Implications on outcome , 2019, Brain Impairment.
[23] Philip D. Harvey. Domains of cognition and their assessment , 2019, Dialogues in clinical neuroscience.
[24] T. Berger,et al. Peripapillary retinal nerve fibre layer thinning rate as a biomarker discriminating stable and progressing relapsing–remitting multiple sclerosis , 2019, European journal of neurology.
[25] R. Benedict,et al. Cognitive Profiles of Aging in Multiple Sclerosis , 2019, Front. Aging Neurosci..
[26] Rehab Magdy,et al. Cognitive and physical disability in Egyptian patients with multiple sclerosis: genetic and optical coherence tomography study , 2019, Neurological research.
[27] A. Drummond,et al. Assessment and management of cognitive problems in people with multiple sclerosis: A National Survey of Clinical Practice , 2019, International journal of clinical practice.
[28] F. Ladstätter,et al. Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis , 2019, Multiple sclerosis.
[29] M. Ermani,et al. D-KEFS ST Failure Identifies Multiple Sclerosis Patients With Worse Objective and Self-Perceived Physical and Cognitive Disability , 2019, Front. Psychol..
[30] E. Karabulut,et al. Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome , 2018, Multiple sclerosis.
[31] Geraint Rees,et al. Association of Retinal Nerve Fiber Layer Thinning With Current and Future Cognitive Decline: A Study Using Optical Coherence Tomography , 2018, JAMA neurology.
[32] F. Paul,et al. Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[33] Philip Wijesinghe,et al. Optical Coherence Tomography of the Tympanic Membrane and Middle Ear: A Review , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[34] G. Fenu,et al. A cross-sectional and longitudinal study evaluating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls , 2018, BMC Neurology.
[35] C. Crainiceanu,et al. Visual Pathway Measures are Associated with Neuropsychological Function in Multiple Sclerosis , 2018, Current eye research.
[36] F. Lublin,et al. Looking into cognitive impairment in primary‐progressive multiple sclerosis , 2018, European journal of neurology.
[37] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[38] Keith L. Black,et al. Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases , 2017, Front. Neurol..
[39] T. Olsson,et al. The Temporal Retinal Nerve Fiber Layer Thickness Is the Most Important Optical Coherence Tomography Estimate in Multiple Sclerosis , 2017, Front. Neurol..
[40] M. Sormani,et al. Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis , 2017, PloS one.
[41] J. Bernard,et al. Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study , 2017, PloS one.
[42] Dong Myung Kim,et al. Ganglion cell-inner plexiform layer and retinal nerve fiber layer thickness according to myopia and optic disc area: a quantitative and three-dimensional analysis , 2017, BMC Ophthalmology.
[43] M. Schoonheim,et al. Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layers , 2017, Multiple sclerosis.
[44] C. Heesen,et al. Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing–remitting MS , 2016, Brain and behavior.
[45] R. Benedict,et al. Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients , 2016, Multiple sclerosis.
[46] S. Khoury,et al. Retinal measures correlate with cognitive and physical disability in early multiple sclerosis , 2016, Journal of Neurology.
[47] Sina Farsiu,et al. Retinal nerve fiber layer thickness in amnestic mild cognitive impairment: Case-control study and meta-analysis , 2016, Alzheimer's & dementia.
[48] M. Ramanathan,et al. Optical coherence tomography and neurodegeneration: are eyes the windows to the brain? , 2016, Expert review of neurotherapeutics.
[49] B. Uitdehaag,et al. Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study , 2016, Journal of Neurology.
[50] C. Trebst,et al. Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients , 2016, Experimental and therapeutic medicine.
[51] F. Ashtari,et al. Association between retinal nerve fiber layer thickness and magnetic resonance imaging findings and intelligence in patients with multiple sclerosis , 2015, Advanced biomedical research.
[52] Francesco Pierelli,et al. Optical Coherence Tomography in Alzheimer’s Disease: A Meta-Analysis , 2015, PloS one.
[53] H. Lassmann. Mechanisms of white matter damage in multiple sclerosis , 2014, Glia.
[54] Hirofumi Ochi,et al. [Cognitive impairment in multiple sclerosis]. , 2014, Brain and nerve = Shinkei kenkyu no shinpo.
[55] S. Saidha,et al. Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Yes , 2014, Multiple sclerosis.
[56] M. Ramanathan,et al. Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients , 2014, European journal of neurology.
[57] Jessica Burggraaff,et al. Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis , 2014, Multiple sclerosis.
[58] S. Rao,et al. Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis , 2014, Multiple sclerosis international.
[59] Chunbo Li,et al. Retinal nerve fiber layer thickness is associated with episodic memory deficit in mild cognitive impairment patients. , 2014, Current Alzheimer research.
[60] F. Paul,et al. Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study , 2013, BMC Neurology.
[61] S. A. Meyer,et al. Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning , 2013, Neurology.
[62] H. Hartung,et al. Brief International Cognitive Assessment for MS (BICAMS): international standards for validation , 2012, BMC Neurology.
[63] Shiv Saidha,et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. , 2012, Brain : a journal of neurology.
[64] S. A. Meyer,et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness , 2011, Multiple sclerosis.
[65] C. Wegner,et al. Inflammation, demyelination, and degeneration - recent insights from MS pathology. , 2011, Biochimica et biophysica acta.
[66] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[67] Amy Conger,et al. Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: A pilot study , 2009, Journal of the Neurological Sciences.
[68] R. Wurtz,et al. Guarding the gateway to cortex: attention in visual thalamus , 2008, Nature.
[69] J. Sepulcre,et al. Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis , 2008, Multiple sclerosis.
[70] R. Benedict,et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) , 2006, Journal of the International Neuropsychological Society.
[71] O Garcea,et al. Cognitive impairment in patients with multiple sclerosis using the Brief Repeatable Battery-Neuropsychology test , 2006, Multiple sclerosis.
[72] Hans Lassmann,et al. Cortical lesions and brain atrophy in MS , 2005, Journal of the Neurological Sciences.
[73] L. Krupp,et al. Cognitive functioning in children and adolescents with multiple sclerosis , 2005, Neurology.
[74] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[75] S. Thompson,et al. Detecting and describing heterogeneity in meta-analysis. , 1998, Statistics in medicine.
[76] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[77] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[78] S. Chandran,et al. Patterns of Cognitive Dysfunction in Progressive MS , 2013, Behavioural neurology.
[79] Robert Zivadinov,et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis , 2011, Journal of Neurology.
[80] Robert H Wurtz,et al. Exploring the pulvinar path to visual cortex. , 2008, Progress in brain research.
[81] C. Casanova,et al. Higher-order motion processing in the pulvinar. , 2001, Progress in brain research.
[82] Velentin Dragoi. Neuroscience Online Chapter 15: Visual Processing: Cortical Pathways , 1997 .
[83] Robert C. Wolpert,et al. A Review of the , 1985 .